Pol Boudes

Pol Boudes

Company: Galectin Therapeutics

Job title: Chief Medical Officer


The Challenges of Developing Drugs for NASH Cirrhosis: The Example of Belapectin 2:00 pm

Addressing cirrhosis in patients with clinical signs of portal hypertension Interrogating therapeutic efficacy and expanding the scope of target patient populations Innovating clinical trial design with adaptive design to determine dose and better understand efficacyRead more

day: Day 1 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.